Lower Close On Google's Earnings Miss
Google's earnings miss weighed the markets down to a lower close with the Dow slipping 8 points to 13,548. Nasdaq tumbled 31 points to 3072.
On the upside
A Food and Drug Administration advisory panel recommended approval of Aegerion's (Nasdaq: AEGR) cholesterol treatment lomitapide.
USG (NYSE: USG) narrowed third quarter losses as revenue rose.
Rumors circulated that Juniper Networks (NYSE: JNPR) may be acquired by EMC (NYSE: EMC).
On the downside
Lexicon Pharmaceuticals (Nasdaq: LXRX) priced its public offering of 17.5 million common shares at the discounted price of $2.25 per share.
Third quarter earnings rose for BB&T (NYSE: BBT) but the results fell short of analyst expectations.
CytRx (Nasdaq: CYTR) priced its offering of 8 million common shares at the discounted price of $2.50 per share.
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks fell 5 points to 837.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here